Bridge Biotherapeutics, Inc. (KOSDAQ:288330)
South Korea flag South Korea · Delayed Price · Currency is KRW
742.00
+7.00 (0.95%)
At close: May 28, 2025, 3:30 PM KST

Bridge Biotherapeutics Market Cap

Bridge Biotherapeutics has a market cap or net worth of 37.79 billion as of May 28, 2025. Its market cap has decreased by -34.25% in one year.

Market Cap
37.79B
Enterprise Value
23.48B
Revenue
11.18M
Ranking
n/a
PE Ratio
n/a
Stock Price
742.00

Market Cap Chart

Since December 20, 2019, Bridge Biotherapeutics's market cap has decreased from 300.15B to 37.79B, a decrease of -87.41%. That is a compound annual growth rate of -31.69%.

History

DateMarket Cap% Change
May 27, 202538.36B-79.71%
Dec 30, 2024189.04B158.57%
Dec 28, 202373.11B-68.32%
Dec 29, 2022230.80B-17.53%
Dec 30, 2021279.85B0.27%
Dec 30, 2020279.09B-12.04%
Dec 30, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition